Ameriprise Financial »

Avita Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2025-12-31 $101k 29k 3.45
2025-09-30 $149k 29k 5.11
2025-06-30 $155k 29k 5.29
2025-03-31 $271k 33k 8.14
2024-12-31 $609k 48k 12.80
2024-09-30 $475k 44k 10.72
2024-06-30 $346k 44k 7.92
2024-03-31 $831k 52k 16.03
2023-09-30 $1.7M 114k 14.61
2023-06-30 $1.9M 115k 17.01
2023-03-31 $1.8M 132k 13.97
2022-12-31 $976k 148k 6.60
2022-09-30 $790k 150k 5.27
2022-06-30 $731k 154k 4.75
2022-03-31 $947k 112k 8.47